Irbesartan Vocate (Irbesartan)

Irbesartan selectively antagonizes angiotensin II type 1 (AT1) receptors on blood vessels and adrenal tissue. By preventing angiotensin II from binding, it reduces vasoconstriction and aldosterone secretion, leading to vessel relaxation, lower blood pressure, and decreased strain on the kidneys.

The appropriate dose of Irbesartan Vocate is determined by the prescribing clinician based on the individual’s blood pressure, kidney function, and overall health status. Patients should follow the exact dosing instructions provided by their healthcare professional.

Safety of irbesartan in pregnancy has not been established, and it is generally avoided because of potential fetal harm. Limited data exist for breastfeeding; therefore, the medication should only be used if the potential benefit outweighs the risk, under medical supervision.

To request Irbesartan Vocate, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan belongs to the ARB class, which blocks the angiotensin II receptor, whereas ACE inhibitors block its formation. Compared with ACE inhibitors, ARBs like irbesartan are less likely to cause cough or angio‑edema, offering a similar blood‑pressure‑lowering effect with a different side‑effect profile.

Irbesartan Vocate should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Irbesartan Vocate is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should not crush or chew the tablet unless specifically instructed by a healthcare professional.

Serious adverse reactions include angio‑edema, which can cause swelling of the face or throat, and acute kidney injury, especially when combined with other drugs that affect renal function. Severe hyperkalemia, marked by very high potassium levels, can also occur and requires prompt medical attention.

Irbesartan Vocate is contraindicated in patients with known hypersensitivity to irbesartan or any component of the formulation. It should also be avoided in individuals with severe hepatic impairment and in those taking other ARBs or ACE inhibitors concurrently, unless specifically directed by a physician.